In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Natera (NTRA – Research Report). The company’s shares ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rhythm Pharmaceuticals (RYTM – Research Report), ...
Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.
After hours: February 21 at 7:16:46 PM EST ...
根据证券交易委员会的文件显示,Tempus AI, Inc.(NASDAQ:TEM)首席执行官兼董事长Eric Lefkofsky近期大量减持了公司股份。Lefkofsky于2月27日以每股58.75美元的价格出售了1,589,028股股票,交易总额约为1.9036亿美元。值得注意的是, InvestingPro 数据显示,该股票在过去一周下跌了近19%,根据InvestingPro的公允价值模型 ...
Natera (NTRA) (ISIN: US6323071042)股票专题,提供今日Natera(NTRA) (ISIN: US6323071042)股票最新股价查询,实时市场行情,走势图表,及Natera Inc(NTRA) (ISIN: US6323071042)股票的专业技术分析,投资者论坛,历史交易数据,最新消息和未来价格预测。 Natera将于6天内发布季度财报 ...